Debates & Insight Sponsored The evolution of pharma social media intelligence Is your company a fully mature user of intelligence from social media, or is it still not tapping into insights?
Partner Content Partner Content Making the most of your remaining communications budget pharmaphorum connect's Mark Walmsley describes seven projects to maximise remaining communications budgets.
Debates & Insight Sponsored Available on demand: Establishing a Solid Foundation for Dig... Available on demand: Join us for a one-hour live webinar entitled Establishing a Solid Foundation for Digital Transformation.
Debates & Insight Sponsored Available on demand: Social medical: The social media buzz a... Join us for a one-hour live webinar discussing the social media buzz around this year’s ASCO Annual Meeting.
Articles Digital health round-up: smart inhalers, 3D printing and mor... A round-up of this week's top digital healthcare news. Marco Ricci reports.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.